Methods and kits for predicting a response to an erythropoietic agent
Abstract
Methods for predicting a response to an erythropoietic agent in a subject include providing a biological sample from the subject, and determining an amount in the sample of at least one peptide selected from the group consisting of SEQ ID NOS: 1-17. If there is a measurable difference in the amount of the at least one peptide in the sample, when compared to a control level of the same peptide, the subject is then predicted to have a good response or a poor response to the erythropoietic agent.
- Inventors:
- Issue Date:
- Research Org.:
- University of Louisville Research Foundation, Inc., Louisville, KY (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1469316
- Patent Number(s):
- 10,041,956
- Application Number:
- 14/712,323
- Assignee:
- University of Louisville Research Foundation, Inc. (Louisville, KY)
- DOE Contract Number:
- FG02-05ER6406
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 2015 May 14
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 59 BASIC BIOLOGICAL SCIENCES
Citation Formats
Merchant, Michael L., Klein, Jon B., Brier, Michael E., and Gaweda, Adam E. Methods and kits for predicting a response to an erythropoietic agent. United States: N. p., 2018.
Web.
Merchant, Michael L., Klein, Jon B., Brier, Michael E., & Gaweda, Adam E. Methods and kits for predicting a response to an erythropoietic agent. United States.
Merchant, Michael L., Klein, Jon B., Brier, Michael E., and Gaweda, Adam E. Tue .
"Methods and kits for predicting a response to an erythropoietic agent". United States. https://www.osti.gov/servlets/purl/1469316.
@article{osti_1469316,
title = {Methods and kits for predicting a response to an erythropoietic agent},
author = {Merchant, Michael L. and Klein, Jon B. and Brier, Michael E. and Gaweda, Adam E.},
abstractNote = {Methods for predicting a response to an erythropoietic agent in a subject include providing a biological sample from the subject, and determining an amount in the sample of at least one peptide selected from the group consisting of SEQ ID NOS: 1-17. If there is a measurable difference in the amount of the at least one peptide in the sample, when compared to a control level of the same peptide, the subject is then predicted to have a good response or a poor response to the erythropoietic agent.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2018},
month = {8}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Method for automatic dosing of drugs
patent, May 2000
- Jacobsen, Stephen; Zentner, Gaylen
- US Patent Document 6,056,734
Method and system for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
patent, July 2001
- McMichael, John
- US Patent Document 6,267,116
Method and apparatus for use in treating a patient with any drug to optimize therapy and prevent an adverse drug
patent, June 2003
- McMichael, John
- US Patent Document 6,575,169
Neural network drug dosage estimation
patent, December 2003
- Tang, Sharon; Diamond, Cornelius; Arouh, Scott
- US Patent Document 6,658,396
Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
patent, June 2004
- Cheung, Wing; Gibson, David; Cote, Christine
- US Patent Document 6,747,002
Systems and methods for medication monitoring
patent, November 2004
- Vrijens, Bernard; Urquhart, John; De Klerk, Erik
- US Patent Document 6,822,554
Method and apparatus for dosing single and multi-agent therapy
patent, April 2005
- McMichael, John
- US Patent Document 6,883,521
Erythropoietin dosing regimen for treating anemia
patent, June 2007
- Farrell, Francis; Jolliffe, Linda
- US Patent Document 7,232,797
Method and apparatus for glucose control and insulin dosing for diabetics
patent, January 2010
- Doyle, Francis; Jovanovic, Lois
- US Patent Document 7,651,845
Differential exoprotease activities confer tumor-specific serum peptidome patterns
journal, December 2005
- Villanueva, Josep; Shaffer, David R.; Philip, John
- Journal of Clinical Investigation, Vol. 116, Issue 1, p. 271-284
Anemia of inflammation: the cytokine-hepcidin link
journal, May 2004
- Andrews, Nancy C.
- Journal of Clinical Investigation, Vol. 113, Issue 9, p. 1251-1253
Specificity of interactions of galectin-3 with Chrp, a cysteine- and histidine-rich cytoplasmic protein
journal, February 2003
- Bawumia, Sulemana; Barboni, Eminia A. M.; Menon, Rajesh P.
- Biochimie, Vol. 85, Issue 1-2, p. 189-194
Oncostatin M Regulates the Synthesis and Turnover of gp130, Leukemia Inhibitory Factor Receptor α, and Oncostatin M Receptor β by Distinct Mechanisms
journal, October 2001
- Blanchard, Frédéric; Wang, Yanping; Kinzie, Erin
- Journal of Biological Chemistry, Vol. 276, Issue 50, p. 47038-47045
Inflammatory Markers and Platelet Aggregation Tests as Predictors of Hemoglobin and Endogenous Erythropoietin Levels in Hemodialysis Patients
journal, January 2002
- Borawski, Jacek; Pawlak, Krystyna; Myśliwiec, Michał
- Nephron, Vol. 91, Issue 4, p. 671-681
Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas
journal, July 2008
- Chen, D. R.; Chu, C-Y.; Chen, C-Y.
- The Journal of Pathology, Vol. 215, Issue 3, p. 290-299
Chairman's Workshop Report: R-HuEPO hyporesponsiveness—who and why?
journal, January 1995
- Danielson, B.; Beguin, Y.; Bommer, J.
- Nephrology Dialysis Transplantation, Vol. 10, Issue supp2, p. 69-73
Model Predictive Control of Erythropoietin Administration in the Anemia of ESRD
journal, January 2008
- Gaweda, Adam E.; Jacobs, Alfred A.; Aronoff, George R.
- American Journal of Kidney Diseases, Vol. 51, Issue 1, p. 71-79
Role of cytokines in the response to erythropoietin in hemodialysis patients
journal, October 1998
- Goicoechea, Marian; Martin, Julio; de Sequera, Patricia
- Kidney International, Vol. 54, Issue 4, p. 1337-1343
Soluble Erythropoietin Receptor Contributes to Erythropoietin Resistance in End-Stage Renal Disease
journal, February 2010
- Khankin, Eliyahu V.; Mutter, Walter P.; Tamez, Hector
- PLoS ONE, Vol. 5, Issue 2, Article No. e9246
Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M.
journal, July 1989
- Malik, N.; Kallestad, J. C.; Gunderson, N. L.
- Molecular and Cellular Biology, Vol. 9, Issue 7, p. 2847-2853
Precision proteomics: The case for high resolution and high mass accuracy
journal, September 2008
- Mann, M.; Kelleher, N. L.
- Proceedings of the National Academy of Sciences, Vol. 105, Issue 47, p. 18132-18138
Cellular Cholesterol Depletion Triggers Shedding of the Human Interleukin-6 Receptor by ADAM10 and ADAM17 (TACE)
journal, June 2003
- Matthews, Vance; Schuster, Björn; Schütze, Stefan
- Journal of Biological Chemistry, Vol. 278, Issue 40, p. 38829-38839
Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine-343-Stat5 axis
journal, March 2006
- Menon, Madhu P.; Karur, Vinit; Bogacheva, Olga
- Journal of Clinical Investigation, Vol. 116, Issue 3, p. 683-694
Interaction of a novel cysteine and histidine-rich cytoplasmic protein with galectin-3 in a carbohydrate-independent manner
journal, March 2000
- Menon, Rajesh P.; Strom, Molly; Hughes, R. Colin
- FEBS Letters, Vol. 470, Issue 3, p. 227-231
Urinary Peptidome May Predict Renal Function Decline in Type 1 Diabetes and Microalbuminuria
journal, July 2009
- Merchant, M. L.; Perkins, B. A.; Boratyn, G. M.
- Journal of the American Society of Nephrology, Vol. 20, Issue 9, p. 2065-2074
Proteomic analysis of renal calculi indicates an important role for inflammatory processes in calcium stone formation
journal, October 2008
- Merchant, Michael L.; Cummins, Timothy D.; Wilkey, Daniel W.
- American Journal of Physiology-Renal Physiology, Vol. 295, Issue 4, p. F1254-F1258
Dual Oncostatin M (OSM) Receptors: Cloning And Characterization Of An Alternative Signaling Subunit Conferring OSM-Specific Receptor Activation
journal, December 1996
- Mosley, Bruce; De Imus, Cyr; Friend, Della
- Journal of Biological Chemistry, Vol. 271, Issue 51, p. 32635-32643
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
journal, May 2004
- Nemeth, Elizabeta; Rivera, Seth; Gabayan, Victoria
- Journal of Clinical Investigation, Vol. 113, Issue 9, p. 1271-1276
Targeted disruption of oncostatin M receptor results in altered hematopoiesis
journal, November 2003
- Tanaka, Minoru; Hirabayashi, Yoko; Sekiguchi, Takashi
- Blood, Vol. 102, Issue 9, p. 3154-3162
Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure
journal, January 2008
- van der Putten, Karien; Braam, Branko; Jie, Kim E.
- Nature Clinical Practice Nephrology, Vol. 4, Issue 1, p. 47-57
Hypoxia-inducible factor 1α is up-regulated by oncostatin M and participates in oncostatin M signaling
journal, March 2009
- Vollmer, Stefan; Kappler, Valérie; Kaczor, Jakub
- Hepatology, Vol. 50, Issue 1, p. 253-260
Secondary analysis of the CHOIR trial epoetin-α dose and achieved hemoglobin outcomes
journal, September 2008
- Szczech, Lynda A.; Barnhart, Huiman X.; Inrig, Jula K.
- Kidney International, Vol. 74, Issue 6, p. 791-798
Epoetin requirements predict mortality in hemodialysis patients
journal, November 2004
- Zhang, Yi; Thamer, Mae; Stefanik, Kevin
- American Journal of Kidney Diseases, Vol. 44, Issue 5, p. 866-876
Erythropoietic therapy for the treatment of anemia in patients with cancer: a valuable clinical and economic option
journal, December 2006
- Cornes, Paul; Coiffier, Bertrand; Zambrowski, Jean-Jacques
- Current Medical Research and Opinion, Vol. 23, Issue 2, p. 357-368